Treat to Target

OP0162 PATTERNS OF CLINICAL JOINT INFLAMMATION IN JUVENILE IDIOPATHIC ARTHRITIS
S. L. Heckert, P. C. E. Hissink Muller, J. M. Van den Berg, D. Schonenberg-Meinema, L. W. A. Van Suijlekom-Smit, M. Van Rossum, Y. Koopman-Keemink, R. Ten Cate, D. M. C. Brinkman, T. Huizinga, C. Allaart, S. A. Bergstra

Annals of the Rheumatic Diseases Jun 2023, 82 (Suppl 1) 107; DOI: 10.1136/annrheumdis-2023-eular.621
OP0035 THE USE OF CHILDHOOD LLDAS: FIRST RESULTS IN A REAL-LIFE LONGITUDINAL CHILDHOOD LUPUS COHORT SHOW GOOD FEASIBILITY BUT DIFFICULT ATTAINMENT
S. Bergkamp, T. Kanagasabapathy, M. Gruppen, T. Kuijpers, A. Nassar-Sheikh Rashid, J. M. Van den Berg, D. Schonenberg-Meinema

Annals of the Rheumatic Diseases Jun 2023, 82 (Suppl 1) 22-23; DOI: 10.1136/annrheumdis-2023-eular.3946
POS1578 JAK INHIBITORS AND VEXAS SYNDROME: A SUCCESSFULLY CASE TREATED WITH FILGOTINIB
S. Bindoli, E. Bertoldo, A. Doria, C. Baggio, P. Sfriso

Annals of the Rheumatic Diseases Jun 2023, 82 (Suppl 1) 1166; DOI: 10.1136/annrheumdis-2023-eular.1020
AB0210 CAN RHEUMATOID ARTHRITIS IMPACT OF DISEASE (RAID) SCORE BE USED AS A PATIENT REPORTED OUTCOME BASED TARGET IN A TREAT-TO-TARGET APPROACH: A PROSPECTIVE STUDY FROM INDIA
P. S Kumar, A. Kumar P H, M. K. Garg, M. Gopalakrishnan

Annals of the Rheumatic Diseases Jun 2023, 82 (Suppl 1) 1289; DOI: 10.1136/annrheumdis-2023-eular.4473
AB0502 PREVALENCE AND ASSOCIATED FACTORS FOR CONVENTIONAL DISEASE MODIFYING ANTI RHEUMATOID DRUG FAILURE IN PATIENTS WITH RHEUMATOID ARTHRITIS IN A TERTIARY CARE HOSPITAL IN SOUTHERN SRI LANKA
A. Ediriweera, S. Fernando, N. Dias, R. Hegodaarachchi, G. Udumalagala Gamage, A. Iranga, K. Deshapriya

Annals of the Rheumatic Diseases Jun 2023, 82 (Suppl 1) 1445-1446; DOI: 10.1136/annrheumdis-2023-eular.611
AB0534 TREATING SYSTEMIC LUPUS ERYTHEMATOSUS IN THE 21ST CENTURY: COMBINING RITUXIMAB WITH BELIMUMAB
B. Issayeva, A. Mesnyankina, E. Aseeva, S. Solovyev, N. Nikishina, S. Issayeva, M. Saparbayeva, A. Amanzholova, A. Razikhova, A. Аbdulgaziz

Annals of the Rheumatic Diseases Jun 2023, 82 (Suppl 1) 1465-1466; DOI: 10.1136/annrheumdis-2023-eular.4260
AB0970 GREAT DIVERSITY IN B/TSDMARD TREATMENT IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS AROUND THE WORLD AND THE COMPARISONS WITH THE 2022 UPDATED ASAS-EULAR RECOMMENDATIONS
F. Y. Wu, I. P. Lee, C. F. Su, S. H. Lin, C. J. Chiang, C. C. Chang, Y. S. Chang

Annals of the Rheumatic Diseases Jun 2023, 82 (Suppl 1) 1704; DOI: 10.1136/annrheumdis-2023-eular.3432
AB1722-PARE LINKING PATIENT PERCEIVED TREATMENT GOALS OF PEOPLE WITH RHEUMATOID ARTHRITIS (RA) AND SEVERE LIMITATIONS IN FUNCTION TO THE INTERNATIONAL CLASSIFICATION OF FUNCTIONING, DISABILITY AND HEALTH (ICF)
M. Teuwen, S. Van Weely, T. P. M. Vliet Vlieland, T. Douw, M. Van Wissen, A. Den Broeder, D. Van Schaardenburg, W. Peter, C. Van den Ende, M. G. J. Gademan

Annals of the Rheumatic Diseases Jun 2023, 82 (Suppl 1) 2097-2098; DOI: 10.1136/annrheumdis-2023-eular.1661
POS0052 FIVE-YEAR FOLLOW-UP OF A 2-YEAR MRI TREAT-TO-TARGET STRATEGY ON RADIOGRAPHIC DAMAGE PROGRESSION IN RHEUMATOID ARTHRITIS PATIENTS IN CLINICAL REMISSION - THE IMAGINE-MORE STUDY
S. Møller-Bisgaard, K. Hørslev-Petersen, L. Midtbøll Ørnbjerg, B. Ejbjerg, M. L. Hetland, J. Møllenbach Møller, R. Christensen, S. M. Nielsen, D. Glinatsi, M. Boesen, K. Stengaard-Pedersen, O. Madsen, B. Jensen, J. A. Villadsen, E. M. Hauge, O. Hendricks, H. M. Lindegaard, N. Steen Krogh, A. G. Jurik, H. Thomsen, M. Østergaard

Annals of the Rheumatic Diseases Jun 2023, 82 (Suppl 1) 235-236; DOI: 10.1136/annrheumdis-2023-eular.711
POS0335 EXOSOMES TRANSMIT DAMAGE SIGNALS FROM INFRAPATELLAR FAT PAD AND EXACERBATE CHONDROCYTE SENESCENCE IN OSTEOARTHRITIS
Y. Cao, J. Ruan, J. Kang, X. Nie, G. Ruan, Z. Zhu, W. Han, S. Tang, C. Ding

Annals of the Rheumatic Diseases Jun 2023, 82 (Suppl 1) 413-414; DOI: 10.1136/annrheumdis-2023-eular.281

Main menu

Treat to Target

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Treat to Target

Pages